UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

Neurology, 2009-11, Vol.73 (18), p.1469-1477

2009

Volltextzugriff (PDF)

The impact of depressive symptoms in early Parkinson disease

Neurology, 2007-07, Vol.69 (4), p.342-347

2007

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

Neurology, 2012-04, Vol.78 (16), p.1229-1236

2012

Volltextzugriff (PDF)

The behavioral spectrum of tic disorders: a community-based study

Neurology, 2002-08, Vol.59 (3), p.414-420

2002

Volltextzugriff (PDF)

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

Neurology, 2006-01, Vol.66 (2), p.250-252

2006

Volltextzugriff (PDF)

Predicting verbal memory decline following anterior temporal lobectomy (ATL)

Neurology, 2003-04, Vol.60 (8), p.1266-1273

2003

Volltextzugriff (PDF)

Prevalence of tics in schoolchildren and association with placement in special education

Neurology, 2001-10, Vol.57 (8), p.1383-1388

2001

Volltextzugriff (PDF)

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG

Neurology, 2006-01, Vol.66 (2), p.250

2006

Volltextzugriff (PDF)

Clinical markers of early disease in persons near onset of Huntington's disease

Neurology, 2001-08, Vol.57 (4), p.658-662

2001

Volltextzugriff (PDF)

Tourette's syndrome in a special education population: a pilot study involving a single school district

Neurology, 1994-04, Vol.44 (4), p.699-699

1994

Volltextzugriff (PDF)

Treatment of ADHD in children with tics: a randomized controlled trial

Neurology, 2002-02, Vol.58 (4), p.527-536

2002

Volltextzugriff (PDF)

A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder

Neurology, 1996-04, Vol.46 (4), p.965-968

1996

Volltextzugriff (PDF)

Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample

Neurology, 2008-04, Vol.70 (16 Pt 2), p.1495

2008

Volltextzugriff (PDF)

An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome

Neurology, 1991-06, Vol.41 (6), p.872-872

1991

Volltextzugriff (PDF)

The early course of the Tourette's syndrome clinical spectrum

Neurology, 1993-09, Vol.43 (9), p.1712-1712

1993

Volltextzugriff (PDF)

The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease

Neurology, 1994-09, Vol.44 (9), p.1756-1756

1994

Volltextzugriff (PDF)

Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease

Neurology, 2006-02, Vol.66 (3), p.408-410

2006

Volltextzugriff (PDF)

Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease

Neurology, 1998-05, Vol.50 (5), p.1366-1373

The Huntington Study Group

1998

Volltextzugriff (PDF)

The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group

Neurology, 1994-09, Vol.44 (9), p.1756

1994

Volltextzugriff (PDF)

335P: Evaluation of the Glutamate Antagonist Remacemide Hydrochloride in Huntington's Disease

Neurology, 1995-07, Vol.45 (7), p.1417

1995

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNeurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Clinical Neurology
(16)
Female
(16)
Humans
(16)
Life Sciences & Biomedicine
(16)
Male
(16)
Neurosciences & Neurology
(16)
Science & Technology
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Neurology
(10)
Adolescent
(7)
Child
(7)
Middle Aged
(7)
Adult
(6)
Double-Blind Method
(5)
Nervous System
(5)
Neuropharmacology
(5)
Pharmacology. Drug Treatments
(5)
Aged
(4)
Headache. Facial Pains. Syncopes. Epilepsia. Intracranial Hypertension. Brain Oedema. Cerebral Palsy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

The impact of depressive symptoms in early Parkinson disease

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

The behavioral spectrum of tic disorders: a community-based study

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

Predicting verbal memory decline following anterior temporal lobectomy (ATL)

Prevalence of tics in schoolchildren and association with placement in special education

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG

Clinical markers of early disease in persons near onset of Huntington's disease

Tourette's syndrome in a special education population: a pilot study involving a single school district

Treatment of ADHD in children with tics: a randomized controlled trial

A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder

Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample

An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome

The early course of the Tourette's syndrome clinical spectrum

The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease

Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease

Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease

The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group

335P: Evaluation of the Glutamate Antagonist Remacemide Hydrochloride in Huntington's Disease

Aktive Filter

Suchergebnisse filtern